LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1

Historical Holders from Q2 2019 to Q3 2023

Type / Class
Debt / NOTE 0.750% 5/1
All holders as of 30 Sep 2023
Q3 2023
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1

Period Principal Value Change Price Investors
2023 Q3 0 $0 -$298,682 0
2023 Q2 300,000 $298,682 -$71,020,895 $0.9956 1
2023 Q1 71,838,000 $71,319,577 +$5,274,286 $0.9927 26
2022 Q4 66,591,000 $65,027,776 -$3,765,173 $0.9731 25
2022 Q3 65,515,065 $63,620,509 -$33,301,456 $0.9698 23
2022 Q2 99,737,000 $96,520,000 -$63,868,614 $0.9625 23
2022 Q1 163,370,304 $159,551,350 -$147,074,042 $0.9768 30
2021 Q4 308,323,081 $309,277,880 -$3,639,868 $1 32
2021 Q3 321,671,858 $323,960,305 -$848,378 $1 38
2021 Q2 323,098,546 $319,930,461 -$15,166,559 $0.9885 43
2021 Q1 336,008,737 $348,627,573 -$134,181,176 $1.04 48
2020 Q4 474,601,474 $451,327,177 -$23,135,199 $0.9484 46
2020 Q3 505,163,049 $458,227,307 +$27,473,180 $0.9057 47
2020 Q2 479,836,374 $423,793,862 -$14,928,946 $0.876 47
2020 Q1 500,126,237 $418,687,950 -$191,611,306 $0.8281 44
2019 Q4 735,378,302 $636,640,277 -$20,703,526 $0.8655 48
2019 Q3 744,169,000 $621,973,473 +$15,191,167 $0.8343 47
2019 Q2 726,411,131 $626,631,807 +$621,342,068 $0.8632 49